FLEX vs SRPT · P/E 23, rev $6.40B vs rev $1.90B
Flex Ltd (FLEX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Flex Ltd (FLEX) is a electronic components company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
FLEX currently screens at market cap $18.12B and trailing P/E 23.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the FLEX and SRPT stock pages for the full models.
Not investment advice.